These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 9102484

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
    Wang C, Qiao Z, Yang L, Ma L, Zhang H, Zhang J.
    Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
    [Abstract] [Full Text] [Related]

  • 7. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM, Visani G, Leopardi G, Motta MR, Rizzi S, Testoni N, Curti A, Tura S.
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [Abstract] [Full Text] [Related]

  • 8. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J, Sanz GF, Martín G, Sempere A, Picón I, Carral A, Larrea L, Martínez J, Soler MA, Bonanad S, López F, Jarque I, Sanz MA.
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [Abstract] [Full Text] [Related]

  • 9. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
    Ball ED, Wilson J, Phelps V, Neudorf S.
    Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
    [Abstract] [Full Text] [Related]

  • 10. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N, Zabelina T, Sonnenberg S, Krüger W, Renges H, Stute N, Finkenstein F, Mayer U, Holstein K, Fiedler W, Colberg H, Sonnen R, Kuse R, Braumann D, Metzner B, del Valle F, Erttmann R, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D.
    Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 13. [Access to bone marrow transplantation in acute myeloblastic leukemia. Study of 52 patients treated in a single center].
    Tomás JF, Calvo JM, Gómez-García de Soria V, Pinilla I, Figuera A, Fernández-Rañada JM.
    Med Clin (Barc); 1997 May 31; 109(1):12-5. PubMed ID: 9303971
    [Abstract] [Full Text] [Related]

  • 14. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D, Labar B, Bogdanic V, Skodlar J, Petrovecki M, Mrsic M, Maravic N, Sneller V, Radman I, Kovacevic-Metelko J.
    Wien Med Wochenschr; 1995 May 31; 145(2-3):61-4. PubMed ID: 7762256
    [Abstract] [Full Text] [Related]

  • 15. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S, Meloni G, Messina C, Pillon M, Proglia A, Lanino E, Caniggia M, Bagnulo S, Pession A, Locatelli F, Italian Pediatric Group for Bone Marrow Transplantation.
    Bone Marrow Transplant; 2001 Jul 31; 28(2):131-6. PubMed ID: 11509930
    [Abstract] [Full Text] [Related]

  • 16. Autologous bone marrow transplantation for acute leukemia: results and prognostic factors in 90 consecutive patients.
    Sierra J, Grañena A, García J, Valls A, Carreras E, Rovira M, Canals C, Martínez E, Puntí C, Algara M.
    Bone Marrow Transplant; 1993 Nov 31; 12(5):517-23. PubMed ID: 8298563
    [Abstract] [Full Text] [Related]

  • 17. [Bone marrow autotransplantation in patients with acute myeloblastic leukemia in primary remission].
    Richard C, Iriondo A, Baro J, Conde E, Hermosa V, Alsar MJ, Gómez Casares MT, Muruzabal MJ, Pérez Encinas M, Zubizarreta A.
    Med Clin (Barc); 1990 Sep 22; 95(9):324-8. PubMed ID: 2280616
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.